首页> 外文期刊>Indian drugs >FORMULATION AND IN VITRO EVALUATION OF GASTRIC FLOATING DRUG DELIVERY SYSTEM FOR CEFPODOXIME PROXETIL BY 3~2TACTORIAL DESIGN
【24h】

FORMULATION AND IN VITRO EVALUATION OF GASTRIC FLOATING DRUG DELIVERY SYSTEM FOR CEFPODOXIME PROXETIL BY 3~2TACTORIAL DESIGN

机译:头孢噻肟酯胃漂浮药物输送系统的3〜2法设计与体外评价

获取原文
获取原文并翻译 | 示例
           

摘要

The purpose of the present study was to develop an optimized gastric floating drug delivery system (GFDDS) containing cefpodoxime proxetil as a model drug by the optimization technique. Hydroxypropyl methylcellulose K4M (HPMC K4M) (X_1) and sodium starch glycolate (SSG) (X_2)were used in formulating GFDDS employing 3~2 factorial design. The two dependent variables considered were total floating time (TFT) and time required for cumulative 90% release of drug (t_(90)). The main effect and interaction terms were quantitatively evaluated using a mathematical model. The results indicate that X_1 and X_2 significantly affected the release properties and floating behaviour. The predicted values agreed well with the experimental values, and the results demonstrate the feasibility of the model in the development of GFDDS.
机译:本研究的目的是通过优化技术开发一种优化的胃漂浮药物输送系统(GFDDS),其中包含头孢泊肟肟酯作为模型药物。采用3〜2析因设计,将羟丙基甲基纤维素K4M(HPMC K4M)(X_1)和羟乙酸淀粉钠(SSG)(X_2)用于配制GFDDS。考虑的两个因变量是总漂浮时间(TFT)和累积释放90%药物所需的时间(t_(90))。使用数学模型定量评估了主要作用和相互作用项。结果表明,X_1和X_2显着影响释放特性和浮动行为。预测值与实验值吻合良好,结果证明了该模型在GFDDS开发中的可行性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号